Marijuana Stocks

Much like the U.S. legal status on marijuana, the verdict on marijuana stocks is still up in the air. While the bulls like to think that the marijuana industry is about to explode with their optimism over the pending decriminalization and legalization of marijuana, the bears view marijuana stocks as a very risky investment to the point that they may be scams. Marijuana Penny Stocks such as Cannabis Science Inc (CBIS) are risky due to fact that they are in a grey legal area. But as Canada’s nascent legal marijuana market blossoms, many pot stocks are worth adding to your portfolio.

Related to Marijuana Stocks:

7 Potential New Stocks That Should Not Go Public

By Tom Taulli, InvestorPlace Contributor
IPO stocks were on a strong pace ... until the WeWork implosion. It looks like this is a wake-up call for investors. So here’s a look at seven companies that may want to hold off on their IPOs.

Investors Should Use Other Metrics to Evaluate Cronos Group Stock

By Will Ashworth, InvestorPlace Contributor
Some believe that Cronos stock overvalued. But if you consider cash on the balance sheet, CRON stock is more than reasonable. 

Even With New CEO, Debt-Laden Rite Aid Stock is Best Avoided for Near Term

By Ian Cooper, InvestorPlace Contributor
RAD stock hasn't benefited when management gave up selling electronic cigarettes while taking on CBD products. That's not the turnaround strategy it needs.

Aurora Cannabis Stock Will Be Boosted by ACB’s Retail Expansion

By Chris Lau, InvestorPlace Contributor
Aurora’s medical cannabis business is strong and can boost ACB stock over time. Also likely to help Aurora stock is ACB's retail expansion.

My Misgivings About Aurora Cannabis Stock Continue to Grow

By Jonathan Berr, InvestorPlace Contributor
A year after legalization, things aren't looking good for ACB stock. I recommend waiting on the sidelines until vaping risks clear up.

Aurora Cannabis Stock Could Climb in the Long-Term

By Todd Shriber, InvestorPlace Contributor
Like all the other marijuana stocks, ACB stock has been beaten up, but Aurora stock may have more potential than its rivals.

The Bubble Has Burst, But Tilray Stock Is More Than a Penny Stock

By Chris Markoch, InvestorPlace Contributor
Tilray stock is hovering near its IPO level. The cannabis bubble has burst, but that doesn't mean TLRY should be treated like a penny stock.

Aurora Cannabis Stock Demonstrates Promising Trading Opportunities

By Nicolas Chahine, InvestorPlace Contributor
ACB stock's trading range is tight and a move is coming. After a 60% drop, much of the fat has been shed and there are breakout lines just above.

Aurora Stock: Why It’s Worthwhile for Speculators

By Tom Taulli, InvestorPlace Contributor
Like just about every other marijuana stock, ACB stock has been in bear mode. But this is creating an interesting opportunity. Here’s a look at why now might be the time to consider Aurora stock.

Have Patience With Aurora Cannabis Stock

By Luke Lango, InvestorPlace Senior Investment Analyst
ACB stock is a long-term winner that won't get on its long-term winning path until near-term operational risks pass.

Why the Slide of Tilray Stock May Continue

By Luke Lango, InvestorPlace Senior Investment Analyst
Tilray stock has been stuck in a multi-quarter decline, and the fundamentals imply that the slide of TLRY stock may not be over.

Hexo Stock Might Rebound in 2020

By Chris Lau, InvestorPlace Contributor
Although HEXO is facing multiple challenges now, including higher costs, the longer term outlook of Hexo stock is upbeat.

Cronos Stock Will Eventually Rebound, but Not Anytime Soon

By Luke Lango, InvestorPlace Senior Investment Analyst
Like many other high quality pot stocks, CRON stock will eventually rebound from this sell-off, but not here, and not now.

It’s All About the Weed for Aphria Stock

By Josh Enomoto, InvestorPlace Contributor
While Aphria’s growth capacity expansion is big news, a more critical catalyst for Aphria stock could be its medicinal marijuana brand.

Why Canopy Growth Stock Can Rise in the Long-Term

By Faisal Humayun, InvestorPlace Contributor
CGC's focus on clinical trials and evidence-based medicinal use is likely to be positive for CGC stock over the long-term.

Is November the Time to Buy Aurora Cannabis Stock?

By Tezcan Gecgil, InvestorPlace Contributor
Unless ACB stock's sales growth translates into profits, there is likely to be little upside potential in the share price.

Holiday Spirits Are High Thanks to Canopy Growth’s Edibles

By Will Ashworth, InvestorPlace Contributor
Cannabis-infused beverages and edibles are now legal in Canada. Canopy Growth has a responsible plan. That’s good for CGC stock. 

The Overblown Squarepocalypse Melodrama Won’t Stop Square Stock

By Josh Enomoto, InvestorPlace Contributor
Square stock may have incurred some negative press from raising its merchant transaction costs, but the overall picture for the company remains bright.

Hexo Stock Is Far Too Dangerous at This Point

By Vince Martin, InvestorPlace Contributor
Hexo stock price is cheaper, but hardly cheap enough for a business that appears to be in disarray.
Load More